Product Detailed Description

Liposomal molybdenum citrate 1% — High Bioavailability Trace Mineral Supplement

Product Overview

liposomal Molybdenum Citrate 1% is a premium-grade dietary supplement ingredient delivering molybdenum citrate in an advanced liposomal delivery system. Molybdenum citrate (CAS 74873-24-8) is the molybdenum salt of citric acid, chemically characterized by the molecular formula C₂₄H₂₀Mo₃O₂₈ and a molecular weight of approximately 1044.2 g/mol. It is a chelated form of molybdenum that has been recognized in the FDA Global Substance Registration System with the unique ingredient identifier (UNII) BQ2CRB3TW9 and is listed in the WHO Drug Dictionary as a defined substance. The "1%" designation indicates that the product contains 1% elemental molybdenum by weight, a specialized concentration designed for precise, low-dose trace mineral supplementation where accurate dosing is critical.

Molybdenum is an essential trace element that is naturally present in many foods and is also available as a dietary supplement. It is a structural constituent of the molybdenum cofactor (Moco), a unique pyranopterin-based cofactor synthesized by the body and required for the function of four enzymes in humans: sulfite oxidase, xanthine oxidoreductase, aldehyde oxidase, and mitochondrial amidoxime reducing component (mARC). These enzymes catalyze key reactions in sulfur metabolism, purine catabolism, and the breakdown of drugs and toxic substances that enter the body.

Why Liposomal Technology?

While molybdenum is generally well absorbed from food sources, with absorption rates ranging from 40–100% depending on various factors including dose and food matrix, there are still benefits to an optimized delivery system. Absorption decreases with increasing doses and is lower when molybdenum is ingested with a meal. Additionally, the 1% concentration format requires precise delivery to ensure consistent trace mineral supplementation.

Liposomal encapsulation provides three critical advantages:

1. Enhanced Stability and Protection — The phospholipid bilayer shields the molybdenum-citrate complex from premature interaction with gastric contents and dietary inhibitors, preserving its intact structure until reaching optimal absorption sites in the small intestine. Molybdenum citrate in the 1% format exhibits excellent stability when stored under proper conditions.

2. Enhanced Cellular Uptake — liposomes fuse directly with intestinal cell membranes, facilitating efficient cellular delivery via lipid-mediated pathways and bypassing passive diffusion limitations. This delivery mechanism complements the aqueous transport pathways utilized by free molybdenum, supporting enhanced systemic absorption.

3. Sustained Release — Liposomal formulations provide controlled release of molybdenum, maintaining consistent active levels for prolonged enzymatic support and reducing the risk of rapid renal excretion. Molybdenum is primarily excreted in the urine, with approximately 90% of ingested molybdenum eliminated through this route, and sustained release supports more efficient utilization of the trace mineral.

Product Specifications

Key Features

• High Purity — Standardized to ≥99% molybdenum citrate (food/pharma grade), with 1% elemental molybdenum content for precise low-dose supplementation.

• Liposomal Enhancement — Phospholipid bilayer encapsulation protects the molybdenum-citrate complex during digestive transit and enhances cellular delivery through lipid-mediated pathways.

• Essential Enzyme Cofactor — Molybdenum is the structural constituent of the molybdenum cofactor (Moco), required for the function of sulfite oxidase, xanthine oxidoreductase, aldehyde oxidase, and mitochondrial amidoxime reducing component (mARC).

• Sulfur Metabolism Support — Molybdenum is a cofactor in the enzyme sulfite oxidase, which detoxifies sulfite to harmless sulfate for excretion. Molybdenum supplementation is recommended for individuals with sulfite sensitivity.

• Uric Acid Metabolism — Molybdenum is required for the activity of xanthine oxidase, which catalyzes the oxidation of hypoxanthine to xanthine and xanthine to uric acid in purine metabolism.

• Detoxification Support — Molybdenum helps break down drugs and toxic substances that enter the body through the aldehyde oxidase and mARC enzyme systems.

• Precise Low-Dose Format — The 1% concentration allows for accurate dosing of this trace mineral, which is essential given the narrow therapeutic window and the Tolerable Upper Intake Level of 2 mg/day.

• Water-Dispersible — Suitable for capsules, tablets, powder drink mixes, and functional beverages.

• Batch Traceability — Complete COA, HPLC chromatogram, and identity data provided for each batch.

Application & Formulation Guidance

Recommended Dosage

The recommended dietary allowance (RDA) for molybdenum is 45 mcg per day for adults 19 years and older, and 50 mcg per day for pregnant and breastfeeding women. Doses ranging between 22–1,500 mcg per day have been used safely and effectively, with 500 mcg daily being the most common dosage. The German Federal Institute for Risk Assessment (BfR) recommends a maximum level of 80 mcg per daily recommended dose for molybdenum in food supplements. The Tolerable Upper Intake Level (UL) for molybdenum is 2,000 mcg per day for adults. For supplemental use, 30–80 mcg daily is commonly used in commercial products. Liposomal formulations may allow for more efficient utilization of lower doses due to enhanced bioavailability.

Shipping & Lead Time

• Stock Orders: 3–5 business days after payment confirmation.

• Bulk / Custom Orders: 2–3 weeks, depending on quantity and customization requirements.

• Shipping Methods: International Express (FedEx, DHL, UPS), air freight, and sea freight.

• Coverage: Worldwide shipping, including remote areas.